Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Winn Chatham

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|August 8, 2024
Macrophage Activation Syndrome in the Setting of Rheumatic DiseasesW Winn Chatham
The Journal of Rheumatology|March 27, 2020
The Rheumatologist's Role in COVID-19Randy Q Cron, W Winn Chatham
The Journal of Rheumatology|May 27, 2020
Drs. Cron and Chatham replyW Winn Chatham, Randy Q Cron
The Journal of Rheumatology|June 10, 2020
Drs. Cron and Chatham replyRandy Q Cron, W Winn Chatham
Nature Clinical Practice. Rheumatology|August 26, 2006
Is febuxostat a more effective treatment for hyperuricemia and gout than allopurinol?W Winn Chatham, Kenneth G Saag
Clinical and Experimental Rheumatology|July 8, 2016
Development of spondyloarthropathy following episodes of macrophage activation syndrome in children with heterozygous mutations in haemophagocytic lymphohistiocytosis-associated genesRandy Q Cron, W Winn Chatham
The Journal of Rheumatology|April 27, 2020
Drs. Cron and Chatham replyRandy Q Cron, W Winn Chatham
Best Practice & Research. Clinical Rheumatology|September 13, 2015
Vasculitis related to viral and other microbial agentsGim Gee Teng, W Winn Chatham
Annual Review of Medicine|October 13, 2022
Cytokine Storm SyndromeRandy Q Cron, Gaurav Goyal, W Winn Chatham
Nature Medicine|September 4, 2021
Calming the cytokine storm in COVID-19Randy Q Cron, Roberto Caricchio, W Winn Chatham
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|August 8, 2024
Macrophage Activation Syndrome in the Setting of Rheumatic DiseasesW Winn Chatham
The Journal of Rheumatology|March 27, 2020
The Rheumatologist's Role in COVID-19Randy Q Cron, W Winn Chatham
The Journal of Rheumatology|May 27, 2020
Drs. Cron and Chatham replyW Winn Chatham, Randy Q Cron
The Journal of Rheumatology|June 10, 2020
Drs. Cron and Chatham replyRandy Q Cron, W Winn Chatham
Nature Clinical Practice. Rheumatology|August 26, 2006
Is febuxostat a more effective treatment for hyperuricemia and gout than allopurinol?W Winn Chatham, Kenneth G Saag
Clinical and Experimental Rheumatology|July 8, 2016
Development of spondyloarthropathy following episodes of macrophage activation syndrome in children with heterozygous mutations in haemophagocytic lymphohistiocytosis-associated genesRandy Q Cron, W Winn Chatham
The Journal of Rheumatology|April 27, 2020
Drs. Cron and Chatham replyRandy Q Cron, W Winn Chatham
Best Practice & Research. Clinical Rheumatology|September 13, 2015
Vasculitis related to viral and other microbial agentsGim Gee Teng, W Winn Chatham
Annual Review of Medicine|October 13, 2022
Cytokine Storm SyndromeRandy Q Cron, Gaurav Goyal, W Winn Chatham
Nature Medicine|September 4, 2021
Calming the cytokine storm in COVID-19Randy Q Cron, Roberto Caricchio, W Winn Chatham
Pageof 5